Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like p... von Lingvay, Ildiko, Cheng, Alice YY, Levine, Joshua A., Gomez‐Valderas, Elisa, Allen, Sheryl E., Ranta, Kari, Torcello‐Gómez, Amelia, Thieu, Vivian T.

Volltext

Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment von Jabbour, Serge, Paik, Jim S., Aleppo, Grazia, Sharma, Palash, Gomez Valderas, Elisa, Benneyworth, Brian D.

Volltext

Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study von Reuter, Uwe, Krege, John H, Lombard, Louise, Gomez Valderas, Elisa, Krikke-Workel, Judith, Dell-Agnello, Grazia, Dowsett, Sherie A, Buse, Dawn C

Volltext

1771083 Switching to tirzepatide 5 mg from GLP-1 RAs: Clinical expectations in the first 12 weeks of treatment von Benneyworth, Brian, Paik, Jim, Jabbour, Serge, Aleppo, Grazia, Sharma, Palash, Valderas, Elisa Gomez

Volltext

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease von Sands, Bruce E., Peyrin-Biroulet, Laurent, Kierkus, Jaroslaw, Higgins, Peter D.R., Fischer, Monika, Jairath, Vipul, Hirai, Fumihito, D’Haens, Geert, Belin, Ruth M., Miller, Debra, Gomez-Valderas, Elisa, Naegeli, April N., Tuttle, Jay L., Pollack, Paul F., Sandborn, William J.

Volltext

Patients achieving a HbA1c <5.7% with ≥5% weight loss and without hypoglycemia: A post hoc analysis of SURPASS 1 to 5 von Cheng, Alice YY, Lingvay, Ildiko, Valderas, Elisa Gomez, Allen, Sheryl Elaine, Ranta, Kari, Levine, Joshua A, Thieu, Vivian Thuyanh, Emmons, Roshni P

Volltext

Patients achieving a HbA1c von Cheng, Alice YY, Lingvay, Ildiko, Elisa Gomez Valderas, Allen, Sheryl Elaine, Ranta, Kari, Levine, Joshua A, Thieu, Vivian Thuyanh, Emmons, Roshni P

Volltext

Abstract #1184056: Tirzepatide Improves Glucose Levels from Baseline Irrespective of Gender: A Post Hoc Analysis of the SURPASS-1 to -5 Studies von Maldonado, Juan, Aleppo, Grazia, Plat, Arian, Valderas, Elisa Gomez, Gorman, Aoife, De Block, Christophe

Volltext

Abstract #1395974: Achieving Waist Circumference Targets with Once Weekly Tirzepatide for the Treatment of Obesity von Neeland, Ian, Cusi, Kenneth, Stefanski, Adam, Sharma, Palash, Valderas, Elisa Gomez, Griffin, Ryan, García-Pérez, Luis-Emilio, Mojdami, Donna

Volltext

717-P: Glycemic Control with Tirzepatide in People with Type 2 Diabetes by Baseline HbA1c =8.5% or >8.5 von ALEPPO, GRAZIA, DE BLOCK, CHRISTOPHE, LEVINE, JOSHUA A., GOMEZ-VALDERAS, ELISA, BENNEYWORTH, BRIAN D.

Volltext

Abstract #1169579: Achievement of HbA1c <6.5% with ≥5% Weight Loss and Without Hypoglycemia in Patients with Type 2 Diabetes Treatment with Tirzepatide: a Post Hoc Analysis of the... von Thieu, Vivian, Lingvay, Ildiko, Choudhary, Pratik, Cheng, Alice, Gomez-Valderas, Elisa, Allen, Sheryl, Ranta, Kari, Levine, Joshua

Volltext

718-P: Patients Achieving an HbA1c <5.7% with =5% Weight Loss and without Hypoglycemia: A Post Hoc Analysis of SURPASS 1 to 5 von CHENG, ALICE Y., LINGVAY, ILDIKO, CHOUDHARY, PRATIK, GOMEZ-VALDERAS, ELISA, ALLEN, SHERYL, RANTA, KARI T., LEVINE, JOSHUA A., THIEU, VIVIAN

Volltext

132 EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE von Sands, Bruce E., Sandborn, William J., Peyrin-Biroulet, Laurent, Higgins, Peter D., Hirai, Fumihito, Jairath, Vipul, D'Haens, Geert, Abreu, Maria T., Belin, Ruth, Valderas, Elisa Gomez, Miller, Debra, Naegeli, April N., Arora, Vipin, Pollack, Paul, Tuttle, Jay, Hibi, Toshifumi

Volltext

1003 – Efficacy and Safety of Mirikizumab (LY3074828) in a Phase 2 Study of Patients with Crohn's Disease von Sands, Bruce E., Sandborn, William J., Peyrin-Biroulet, Laurent, Higgins, Peter D., Hirai, Fumihito, Belin, Ruth, Valderas, Elisa Gomez, Miller, Debra, Morgan-Cox, MaryAnn, Naegeli, April N., Pollack, Paul, Tuttle, Jay, Hibi, Toshifumi

Volltext

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program von Allen, Sheryl Elaine, Cheng, Alice, Choudhary, Pratik, Levine, Joshua A, Ranta, Kari, Thieu, Vivian Thuyanh, Valderas, Elisa Gomez, Lingvay, Ildiko

Volltext